ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $657,616 | +45.1% | 24,474 | +92.6% | 0.08% | +2.7% |
| Q2 2023 | $453,239 | -55.6% | 12,710 | -68.4% | 0.08% | -64.8% |
| Q1 2023 | $1,020,470 | +180.3% | 40,176 | +407.5% | 0.21% | +334.7% |
| Q1 2022 | $364,000 | -46.6% | 7,916 | -3.8% | 0.05% | -49.0% |
| Q2 2021 | $682,000 | -40.8% | 8,230 | -45.2% | 0.10% | -63.8% |
| Q1 2021 | $1,153,000 | 0.0% | 15,030 | 0.0% | 0.26% | +1.1% |
| Q4 2020 | $1,153,000 | +76.0% | 15,030 | -1.2% | 0.26% | +84.5% |
| Q3 2020 | $655,000 | +9.0% | 15,211 | -27.2% | 0.14% | -8.4% |
| Q1 2020 | $601,000 | +38.5% | 20,900 | -11.7% | 0.16% | +573.9% |
| Q1 2019 | $434,000 | -79.2% | 23,666 | -78.3% | 0.02% | -81.9% |
| Q3 2018 | $2,089,000 | – | 108,984 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |